Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Illumina Inc (NQ: ILMN )

116.09 -1.91 (-1.62%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 12, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,612,071
Open 118.46
Bid (Size) 115.50 (3)
Ask (Size) 116.75 (1)
Prev. Close 118.00
Today's Range 115.42 - 119.94
52wk Range 86.58 - 190.31
Shares Outstanding 146,700,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Here's How Much You Would Have Made Owning Illumina Stock In The Last 20 Years
Via Benzinga
What's Going On With 10x Genomics Stock On Wednesday?
Illumina acquires Fluent BioSciences to enhance single-cell analysis and multiomics research. 10x Genomics faces challenges as shares drop amid competitive pricing pressures in the single-cell market. 
Via Benzinga

Performance

YTD
-13.28%
-13.28%
1 Month
+9.27%
+9.27%
3 Month
-1.50%
-1.50%
6 Month
-11.69%
-11.69%
1 Year
-36.23%
-36.23%

More News

Read More
Illumina Buys Fluent BioSciences To Gain Stronger Foothold In Single-Cell Analysis
Via Benzinga
SMART Global Posts Upbeat Results, Joins Aehr Test Systems, MarineMax And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
3 Of the Best ETFs to Buy for AI Stocks Exposure
Via InvestorPlace
Topics Artificial Intelligence ETFs
Exposures Artificial Intelligence
A Glimpse Into The Expert Outlook On Illumina Through 10 Analysts
Via Benzinga
The 3 Best Gene Editing Stocks to Buy in July 2024
Via InvestorPlace
3 Biotech Stocks Turning DNA Dreams Into Dollars
Via InvestorPlace
The 3 Best Personalized Medicine Stocks to Buy in July 2024
Via InvestorPlace
GRAL Stock Alert: 7 Things to Know as Grail Starts Trading Today
Via InvestorPlace
Once Valued At Around $7B, Cancer Blood Test Developer Grail To Kickstart Trading On NASDAQ
Via Benzinga
Large-Cap Stocks In Trouble: Here Are The 10 Worst Performers Over The Past 12 Months - Sunday, June 23
Via Talk Markets
3 Stocks to Buy That Are NOT in the S&P 500 (but Should Be)
Via InvestorPlace
Topics Stocks
Exposures US Equities
Meet the Newest Artificial Intelligence (AI) Stock in the S&P 500. It's Up 266% Since Last Year, and Wall Street Says It's Still a Buy Today
Via The Motley Fool
Topics Artificial Intelligence Stocks
Exposures Artificial Intelligence US Equities
The Watchlist: 3 Stock Spinoffs Coming Soon (Be Ready to Buy)
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Meet the Newest Artificial Intelligence (AI) Stock in the S&P 500. It Ranks Among the Fastest-Growing Enterprise Software Companies.
Via The Motley Fool
Topics Artificial Intelligence Stocks
Exposures Artificial Intelligence US Equities
Amazon, Natera And A Financial Stock: CNBC's 'Final Trades'
Via Benzinga
Here's Why Stocks Such as CrowdStrike and KKR Jumped Today, Whereas Stocks Such as Illumina Dropped
Via The Motley Fool
Topics Stocks
Exposures US Equities
KKR Stock Pops 10% on June 21 Inclusion in the S&P 500
Via InvestorPlace
Topics Stocks
Exposures US Equities
GDDY Stock Alert: GoDaddy Will Join the S&P 500 on June 21
Via InvestorPlace
Topics Stocks
Exposures US Equities
Palantir Was Left Out of the S&P 500; It Still Looks Like a Buy
Via MarketBeat
Topics Stocks
Exposures US Equities
CrowdStrike Holdings Stock Is Surging Monday: What's Going On?
Via Benzinga
Topics Stocks
Exposures US Equities
Arm And Boeing Were Among 10 Large Cap Stocks That Shined The Brightest Last Week (June 1-June 7, 2024): Are They In Your Portfolio?
Via Benzinga
Cybersecurity Provider CrowdStrike And These 2 Companies Make The Cut For S&P 500 Inclusion, Palantir Misses Out Yet Again
Via Benzinga
Topics Stocks
Exposures US Equities
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.